depression
NeuroKaire Raises $10M to Advance Test for Personalizing Depression Treatment
The company said it will also use the funds to scale operations and expand partnerships with drugmakers.
The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the Kiddose PGx test.
Arrivo BioVentures to Explore Biomarkers in Phase I Trial of Drug Candidate for Depression in Women
In a post hoc analysis within a prior Phase II study, the company found SP-624 improved symptoms in female patients with major depressive disorder.
PGx-Guided Depression Treatment Could Save Canadian Province C$956M Over 20 Years, Study Suggests
Premium
A new analysis suggests the cost of setting up PGx testing in British Columbia may be quickly offset due to fewer patients with treatment-resistant depression.
There's evidence that smoking changes how the CYP1A2 gene is expressed, which could result in some smokers needing higher doses of certain drugs.